Financials

  • Market Capitalization N/A
  • Employee 159
  • Founded 2004
  • CEO N/A
  • Website www.molecularpartners.com
  • Headquarter Switzerland
  • FIGI BBG010B7DHZ0
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
Price to sales ratio
Dividends per share
Dividend yield %

Molecular Partners AG - American Depositary Shares

Molecular Partners AG is a clinical-stage biopharmaceutical company based in Zürich, Switzerland. The company is developing a new class of potent, specific and versatile small-protein therapies called DARPins, with potential clinical applications in a range of disease areas including oncology, immuno-oncology, ophthalmology, and infectious diseases. Molecular Partners currently has two DARPin molecules in clinical development, and a broad pipeline of molecules in preclinical development.

Notícias